Sulfonation in pharmacology and toxicology

Drug Metabolism Reviews

Volumn 36, Issue 3-4, 2004, Pages 823-843

  Kauffman, Frederick C ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

PAPS; Sulfatase; Sulfation; Sulfonation; Sulfotransferase; SULT

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; ALKANOL; ALKENE DERIVATIVE; ANDROGEN; APOMORPHINE; AROMATIC AMIDE; AROMATIC AMINE; ARYLSULFATASE; ASCORBIC ACID; BENZENE DERIVATIVE; BENZYL ALCOHOL DERIVATIVE; BILE ACID; BUDESONIDE; CATECHOLAMINE; CHOLESTEROL; CURCUMIN; EPICATECHIN; ESTROGEN; ETHINYLESTRADIOL; FLAVONOID; IODOTHYRONINE; MINOXIDIL; NEUROSTEROID; PARACETAMOL; PRASTERONE; STEROID; SULFOTRANSFERASE; TAMOXIFEN; TOXIC SUBSTANCE; VITAMIN D;

CARCINOGENESIS; CATALYSIS; CATECHOLAMINE METABOLISM; CELL MEMBRANE TRANSPORT; DRUG METABOLISM; ENDOPLASMIC RETICULUM; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; PHARMACOGENETICS; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; STEROIDOGENESIS; SULFONATION; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; HUMANS; PHARMACEUTICAL PREPARATIONS; SULFOTRANSFERASES; TOXICOLOGY;

EID: 7544251780     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-200033496     Document Type: Review

References (136)

1. Adjei, A. A., Weinshilboum, R. M. (2002). Catecholestrogen sulfation: possible role in carcinogenesis. Biochem. Biophys. Res. Commun. 292:402-408.
2. Adjei, A. A., Thomae, B. A., Prondzinski, J. L., Eckloff, B. W., Wieben, E. D., Weinshilboum, R. M. (2003). Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics. Br. J. Pharmacol. 139:1373-1382.
3. Aldred, S., Waring, R. H. (1999). Localisation of dehydroepiandrosterone sulphotransferase in adult rat brain. Brain Res. Bull. 48:291-296. [In Process Citation].
4. Axelson, M. (1985). 25-Hydroxyvitamin D3 3-sulphate is a major circulating form of vitamin D in man. FEBS Lett. 191:171-175.
5. Bamber, D. E., Fryer, A. A., Strange, R. C., Elder, J. B., Deakin, M., Rajagopal, R., Fawole, A., Gilissen, R. A., Campbell, F. C., Coughtrie, M. W. (2001). Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11:679-685.
6. Barker, E. V., Hume, R., Hallas, A., Coughtrie, M. W. H. (1994). Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology 134:982-989.
7. Baulieu, E. E. (1998). Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963-987.
8. Baumann, E. (1876). Ueber sulfosauren im harn. Ber. Dtsch. Chem. 54-58.
9. Besset, S., Vincourt, J. B., Amalric, F., Girard, J. P. (2000). Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells. FASEB J. 14:345-354.
10. Boberg, E. W., Miller, E. C., Miller, J. A., Poland, A., Liem, A. (1983). Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res. 43:5163-5173.
11. Bock, K. W., Frohling, W., Remmer, H., Rexer, B. (1973). Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim. Biophys. Acta 327:46-56.
12. Buist, S. C., Cherrington, N. J., Klaassen, C. D. (2003). Endocrine regulation of rat organic anion transporters. Drug Metab. Dispos. 31:559-564.
13. Buonarati, M. H., Turteltaub, K. W., Shen, N. H., Felton, J. S. (1990). Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl- 6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Mutat. Res. 245:185-190.
14. Buu, N. T., Duhaime, J., Savard, C., Truong, L., Kuchel, O. (1981). Presence of conjugated catecholamines in rat brain: a new method of analysis of catecholamine sulfates. J. Neurochem. 36:769-772.
15. Cascio, C., Guarneri, R., Russo, D., De Leo, G., Guarneri, M., Piccoli, F., Guarneri, P. (2000). Pregnenolone sulfate, a naturally occurring excitotoxin involved in delayed retinal cell death. J. Neurochem. 74:2380-2391.
16. Chang, H. J., Shi, R., Rehse, P., Lin, S. X. (2004). Identifying androsterone (ADT) as a cognate substrate for human dehydroepiandrosterone sulfotransferase (DHEA-ST) important for steroid homeostasis: structure of the enzyme-ADT complex. J. Biol. Chem. 279:2689-2696.
17. Chen, G., Yin, S., Maiti, S., Shao, X. (2002). 4-Hydroxytamoxifen sulfation metabolism. J. Biochem. Mol. Toxicol. 16:279-285.
18. Chu, X. Y., Huskey, S. E. W., Braun, M. P., Sarkadi, B., Evans, D. C., Evers, R. (2004). Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3. J. Pharmacol. Exp. Ther. 309:156-164.
19. Coughtrie, M. W. (2002). Sulfation through the looking glass - recent advances in sulfotransferase research for the curious. Pharmacogenomics J. 2:297-308.
20. Coughtrie, M. W., Johnston, L. E. (2001). Interactions between dietary chemicals and human sulfotransferases - molecular mechanisms and clinical significance. Drug Metab. Dispos. 29:522-528.
21. Coughtrie, M. W., Sharp, S., Maxwell, K., Innes, N. P. (1998). Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem.-Biol. Interact. 109:3-27.
22. Coughtrie, M. W., Gilissen, R. A., Shek, B., Strange, R. C., Fryer, A. A., Jones, P. W., Bamber, D. E. (1999). Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem. J. 337(Pt. 1):45-49.
23. Dooley, T. P. (1999). Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin. Exp. Dermatol. 8:328-329.
24. Duffel, M. W., Marshal, A. D., McPhie, P., Sharma, V., Jakoby, W. B. (2001). Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab. Rev. 33:369-395.
25. Echchgadda, I., Song, C. S., Roy, A. K., Chatterjee, B. (2004). Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol. Pharmacol. 65:720-729.
26. Eisenhofer, G., Coughtrie, M. W., Goldstein, D. S. (1999). Dopamine sulphate: an enigma resolved. Clin. Exp. Pharmacol. Physiol. Suppl. 26:S41-S53.
27. Estensen, R. D., Jordan, M. M., Wiedmann, T. S., Galbraith, A. R., Steele, V. E., Wattenberg, L. W. (2004). Effect of chemopreventive agents on separate stages of progression of benzo[{alpha}]pyrene induced lung tumors in A/J mice. Carcinogenesis 25:197-201.
28. Falany, C. N., Xie, X., Wang, J., Ferrer, J., Falany, J. L. (2000). Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. Biochem. J. 346(Pt. 3):857-864.
29. Flood, J. F., Farr, S. A., Johnson, D. A., Li, P. K., Morley, J. E. (1999). Peripheral steroid sulfatase inhibition potentiates improvement of memory retention for hippocampally administered dehydroepiandrosterone sulfate but not pregnenolone sulfate. Psychoneuroendocrinology 24:799-811.
30. Frye, C. A., Lacey, E. H. (1999). The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state. Physiol. Behav. 66:85-92.
31. Fuda, H., Lee, Y. C., Shimizu, C., Javitt, N. B., Strott, C. A. (2002). Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1 isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol sulfotransferase, whereas exon 1A yields pregnenolone sulfotransferase. J. Biol. Chem. 277:36161-36166.
32. Glatt, H. (2000). Sulfotransferases in the bioactivation of xenobiotics. Chem.-Biol. Interact. 129:141-170.
33. Glatt, H., Meinl, W. (2004). Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity. Carcinogenesis 25:779-786.
34. Glatt, H., Pauly, K., Czich, A., Falany, J. L., Falany, C. N. (1995). Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli. Eur. J. Pharmacol. 293:173-181.
35. Glatt, H., Davis, W., Meinl, W., Hermersdorfer, H., Venitt, S., Phillips, D. H. (1998). Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture. Carcinogenesis 19:1709-1713.
36. Glatt, H., Engelke, C. E. H., Pabel, U., Teubner, W., Jones, A. L., Coughtrie, M. W. H., Andrae, U., Falany, C. N., Meinl, W. (2000). Sulfotransferases: genetics and role in toxicology. Toxicol. Lett. 112-113:341-348.
37. Glatt, H., Boeing, H., Engelke, C. E. H., Ma, L., Kuhlow, A., Pabel, U., Pomplun, D., Teubner, W., Meinl, W. (2001). Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat. Res. Fundam. Mol. Mech. Mutagen. 482:27-40.
38. Haenen, G. R. M. M., Jansen, F. P., Vermeulen, N. P. E., Bast, A. (1991). Activation of the microsomal glutathione S-transferase by metabolities of a-methyldopa. Arch. Biochem. Biophys. 287:48-52.
39. Hely, M. A., Fung, V. S. C. (2000). Treatment of Parkinson's disease. J. Clin. Neurosci. 7:484-494.
40. Her, C., Wood, T. C., Eichler, E. E., Mohrenweiser, H. W., Ramagli, L. S., Siciliano, M. J., Weinshilboum, R. M. (1998). Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics 53:284-295.
41. Hojo, Y., Hattori, T. A., Enami, T., Furukawa, A., Suzuki, K., Ishii, H. T., Mukai, H., Morrison, J. H., Janssen, W. G., Kominami, S., Harada, N., Kimoto, T., Kawato, S. (2004). Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U. S. A. 101:865-870.
42. Hume, R., Richard, K., Kaptein, E., Stanley, E. L., Visser, T. J., Coughtrie, M. W. (2001). Thyroid hormone metabolism and the developing human lung. Biol. Neonate 80 (Suppl. 1):18-21.
43. Ireson, C. R., Jones, D. J. L., Orr, S., Coughtrie, M. W. H., Boocock, D. J., Williams, M. L., Farmer, P. B., Steward, W. P., Gescher, A. J. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomark. Prev. 11:105-111.
44. Jones, A. L., Roberts, R. C., Colvin, D. W., Rubin, G. L., Coughtrie, M. W. (1995). Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine. Eur. J. Clin. Pharmacol. 49:109-114.
45. Jonsson, G., Astrom, A., Andersson, P. (1995). Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab. Dispos. 23:137-142.
46. Kalsi, J., Kell, P. (2004). Update on oral treatments for male erectile dysfunction. J. Eur. Acad. Dermatol. Venereol. 18:267-274.
47. Kauffman, F. C., Whittaker, M., Anundi, I., Thurman, R. G. (1991). Futile cycling of a sulfate conjugate by isolated hepatocytes. Mol. Pharmacol. 39:414-420.
48. Kester, M. H., Bulduk, S., Tibboel, D., Meinl, W., Glatt, H., Falany, C. N., Coughtrie, M. W., Bergman, A., Safe, S. H., Kuiper, G. G., Schuur, A. G., Brouwer, A., Visser, T. J. (2000). Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141:1897-1900.
49. Kester, M. H., Kaptein, E., van Dijk, C. H., Roest, T. J., Tibboel, D., Coughtrie, M. W., Visser, T. J. (2002). Characterization of iodothyronine sulfatase activities in human and rat liver and placenta. Endocrinology 143:814-819.
50. Kester, M. H. A., Kaptein, E., Roest, T. J., van Dijk, C. H., Tibboel, D., Meinl, W., Glatt, H., Coughtrie, M. W. H., Visser, T. J. (2003). Characterization of rat iodothyronine sulfotransferases. Am. J. Physiol. Endocr. Metab. 285:E592-E598.
51. King, C. M., Phillips, B. (1968). Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid. Science 159:1351-1353.
52. Kitada, H., Miyata, M., Nakamura, T., Tozawa, A., Honma, W., Shimada, M., Nagata, K., Sinai, C. J., Guo, G. L., Gonzalez, F. J., Yamazoe, Y. (2003). Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J. Biol. Chem. 278:17838-17844.
53. Klaassen, C. D., Bowles, J. W. (1997). The importance of 3′-phophoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11:404-418.
54. Krueger, K. E., Papadopoulos, V. (1992). Mitochondrial benzodiazapines receptors and the regulation of steroid biosynthesis. Annu. Rev. Pharmacol. Toxicol. 32:211-237.
55. LeWitt, P. A. (2004). Subcutaneously administered apomorphine: pharmacokinetics and metabolism. Neurology 62:S8-S11.
56. Li, X., Anderson, R. J. (1999). Sulfation of iodothyronines by recombinant human liver steroid sulfotransferases. Biochem. Biophys. Res. Commun. 263:632-639.
57. Li, X., Clemens, D. L., Anderson, R. J. (2000). Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)*. Biochem. Pharmacol. 60:1713-1716.
58. Li, X., Clemens, D. L., Cole, J. R., Anderson, R. J. (2001). Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3′, 5-triiodothyronine as the substrate. J. Endocrinol. 171:525-532.
59. Liang, G., Miao, X., Zhou, Y., Tan, W., Lin, D. (2003). A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 63:3987-3990.
60. Liyou, N. E., Buller, K. M., Tresillian, M. J., Elvin, C. M., Scott, H. L., Dodd, P. R., Tannenberg, A. E., McManus, M. E. (2003). Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study. J. Histochem. Cytochem. 51:1655-1664.
61. Lyle, S., Stanczak, J., Ng, K., Schwartz, N. B. (1994). Rat chondrosarcoma ATP sulfurylase and adenosine 5′-phosphosulfate kinase reside on a single bifunctional protein. Biochemistry 33:5920-5925.
62. Mancini, M. A., Song, C. S., Rao, T. R., Chatterjee, B., Roy, A. K. (1992). Spatio-temporal expression of estrogen sulfotransferase within the hepatic lobule of male rats: implication of in situ estrogen inactivation in androgen action. Endocrinology 131:1541-1546.
63. Markowski, M., Ungeheuer, M., Bitran, D., Locurto, C. (2001). Memory-enhancing effects of DHEAS in aged mice on a win-shift water escape task. Physiol. Behav. 72:521-525.
64. Meisheri, K. D., Garland, M., Johnson, A., Puddinoton, L. (1993). Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil. Biochem. Pharmacol. 45:271-279.
65. Melchior, C. L., Allen, P. M. (1992). Interaction of pregnanolone and pregnenolone sulfate with ethanol and pentobarbital. Pharmacol. Biochem. Behav. 42:605-611.
66. Meloche, C. A., Sharma, V., Swedmark, S., Andersson, P., Falany, C. N. (2002). Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST). Drug Metab. Dispos. 30:582-585.
67. Mensah-Nyagan, A. G., Do-Rego, J. L., Beaujean, D., Luu-The, V., Pelletier, G., Vaudry, H. (1999). Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51:63-81.
68. Mesia-Vela, S., Kauffman, F. C. (2003). Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica 33:1211-1220.
69. Meyer, D. A., Carta, M., Partridge, L. D., Covey, D. F., Valenzuela, C. F. (2002). Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigmal-like receptors. J. Biol. Chem. 277:28725-28732.
70. Migues, P. V., Johnston, A. N., Rose, S. P. (2002). Dehydroepiandosterone and its sulphate enhance memory retention in day-old chicks. Neuroscience 109:243-251.
71. Miller, J. A. (1970). Carcinogenesis by chemicals: an overview. Cancer Res. 30:559-576.
72. Miller, J. A., Surh, Y.-J. (1994). Sulfonation in chemical carcinogenesis. In: Kauffman, F. C., ed. Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. New York: Springer-Verlag, pp. 429-457.
73. Monnet, F. P., Mahe, V., Robel, P., Baulieu, E. E. (1995). Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. U. S. A. 92:3774-3778.
74. Mulder, G. J., Jakoby, W. B. (1990). Sulfation. In: Mulder, G. J., ed. Conjugation Reactions in Drug Metabolism. New York: Taylor and Francis, pp. 107-161.
75. Nagata, K., Yamazoe, Y. (2000). Pharmacogenetics of sulfotransferase. Annu. Rev. Pharmacol Toxicol. 40:159-176.
76. Nagata, K., Ozawa, S., Miyata, M., Shimada, M., Gong, D. W., Yamazoe, Y., Kato, R. (1993). Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2- acetylaminofluorene. J. Biol. Chem. 268:24720-24725.
77. Nowell, S., Sweeney, C., Winters, M., Stone, A., Lang, N. P., Hutchins, L. F., Kadlubar, F. F., Ambrosone, C. B. (2002). Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J. Natl. Cancer Inst. 94:1635-1640.
78. Nowell, S., Coles, B., Sinha, R., MacLeod, S., Luke Ratnasinghe, D., Stotts, C., Kadlubar, F. F., Ambrosone, C. B., Lang, N. P. (2002). Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat. Res. Fundam. Mol. Mech. Mutagen. 506-507:175-185.
79. Nowell, S., Ratnasinghe, D. L., Ambrosone, C. B., Williams, S., Teague-Ross, T., Trimble, L., Runnels, G., Carrol, A., Green, B., Stone, A., Johnson, D., Greene, G., Kadlubar, F. F., Lang, N. P. (2004). Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol. Biomark. Prev. 13:270-276.
80. O'Connell, E. J. (2003). Review of the unique properties of budesonide. Clin. Ther. 25 (Suppl C):C42-C60.
81. Orentreich, N., Brind, J. L., Rizer, R. L., Vogelman, J. H. (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59:551-555.
82. Pai, T. G., Suiko, M., Sakakibara, Y., Liu, M. C. (2001). Sulfation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases. Biochem. Biophys. Res. Commun. 285:1175-1179.
83. Palmer, R. H., Bolt, M. G. (1971). Bile acid sulfates. I. Synthesis of lithocholic acid sulfates and their identification in human bile. J. Lipid Res. 12:671-679.
84. Peterson, T. G., Ji, G. P., Kirk, M., Coward, L., Falany, C. N., Barnes, S. (1998). Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. Am. J. Clin. Nutr. 68:1505S-1511S.
85. Petrotchenko, E. V., Pedersen, L. C., Borchers, C. H., Tomer, K. B., Negishi, M. (2001). The dimerization motif of cytosolic sulfotransferases. FEBS Lett. 490:39-43.
86. Purinton, S. C., Wood, C. E. (2000). Ovine fetal estrogen sulfotransferase in brain regions important for hypothalamus-pituitary-adrenal axis control. Neuroendocrinology 71:237-242.
87. Qian, Y. M., Sun, X. J., Tong, M. H., Li, X. P., Richa, J., Song, W. C. (2001). Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 142:5342-5350.
88. Raftogianis, R. B., Wood, T. C., Otterness, D. M., Van Loon, J. A., Weinshilboum, R. M. (1997). Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype*1. Biochem. Biophys. Res. Commun. 239:298-304.
89. Ranasinghe, J. G., Liu, M. C., Sakakibara, Y., Suiko, M. (2000). Manganese administration induces the increased production of dopamine sulfate and depletion of dopamine in Sprague-Dawley rats. J. Biochem. (Tokyo) 128:477-480.
90. Reiter, C., Weinshilboum, R. (1982). Platelet phenol sulfotransferase activity: correlation with sulfate conjugation of acetaminophen. Clin. Pharmacol. Ther. 32:612-621.
91. Remmer, H., Bock, K. W., Rexer, B. (1975). Relationship between microsomal hydroxylase and glucuronyltransferase. Adv. Exp. Med. Biol. 58:335-341.
92. Rhodes, M. E., Li, P. K., Flood, J. F., Johnson, D. A. (1996). Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res. 733:284-286.
93. Rhodes, M. E., Li, P.-K., Burke, A. M., Johnson, D. A. (1997). Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 773:28-32.
94. Richard, K., Hume, R., Kaptein, E., Stanley, E. L., Visser, T. J., Coughtrie, M. W. (2001). Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J. Clin. Endocrinol. Metab. 86:2734-2742.
95. Rivett, A. J., Eddy, B. J., Roth, J. A. (1982). Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain. J. Neurochem. 39:1009-1016.
96. Robbins, P. W., Lippman, F. (1957). Isolation and identification of active sulfate. J. Biol. Chem. 229:837-851.
97. Roth, J. A., Rivett, A. J. (1982). Does sulfate conjugation contribute to the metabolic inactivation of catecholamines in humans? Biochem. Pharmacol. 31:3017-3021.
98. Rubin, G. L., Harrold, A. J., Mills, J. A., Falany, C. N. (1999). Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Mol. Human Reprod. 5:995-1002.
99. Runge-Morris, M., Wu, W., Kocarek, T. A. (1999). Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Mol. Pharmacol. 56:1198-1206.
100. Saintot, M., Malaveille, C., Hautefeuille, A., Gerber, M. (2003). Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. Int. J. Cancer 107:652-657.
101. Sakakibara, Y., Yanagisawa, K., Katafuchi, J., Ringer, D. P., Takami, Y., Nakayama, T., Suiko, M., Liu, M. C. (1998). Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2- acetylaminofluorene. J. Biol. Chem. 273:33929-33935.
102. Sakakibara, Y., Suiko, M., Pai, T. G., Nakayama, T., Takami, Y., Katafuchi, J., Liu, M. C. (2002). Highly conserved mouse and human brain sulfotransferases: molecular cloning, expression, and functional characterization. Gene 285:39-47.
103. Seth, P., Lunetta, K. L., Bell, D. W., Gray, H., Nasser, S. M., Rhei, E., Kaelin, C. M., Iglehart, D. J., Marks, J. R., Garber, J. E., Haber, D. A., Polyak, K. (2000). Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res. 60:6859-6863.
104. Shen, W., Mennerick, S., Covey, D. F., Zorumski, C. F. (2000). Pregnenolone sulfate modulates inhibitory synaptic transmission by enhancing GABA(A) receptor desensitization. J. Neurosci. 20:3571-3579.
105. Shibuya, K., Takata, N., Hojo, Y., Furukawa, A., Yasumatsu, N., Kimoto, T., Enami, T., Suzuki, K., Tanabe, N., Ishii, H., Mukai, H., Takahashi, T., Hattori, T. A., Kawato, S. (2003). Hippocampal cytochrome P450s synthesize brain neurosteroids which are paracrine neuromodulators of synaptic signal transduction. Biochim. Biophys. Acta 1619:301-316.
106. Shimada, M., Yoshinari, K., Tanabe, E., Shimakawa, E., Kobashi, M., Nagata, K., Yamazoe, Y. (2001). Identification of ST2A1 as a rat brain neurosteroid sulfotransferase mRNA. Brain Res. 920:222-225.
107. Song, C. S., Echchgadda, I., Baek, B. S., Ahn, S. C., Oh, T., Roy, A. K., Chatterjee, B. (2001). Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J. Biol. Chem. 276:42549-42556.
108. Steckelbroeck, S., Nassen, A., Ugele, B., Ludwig, M., Watzka, M., Reissinger, A., Clusmann, H., Lutjohann, D., Siekmann, L., Klingmuller, D., Hans, V. H. (2004). Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study. J. Neurochem. 89:403-417.
109. Strott, C. A. (2002). Sulfonation and molecular action. Endocr. Rev. 23:703-732.
110. Strott, C. A., Higashi, Y. (2003). Cholesterol sulfate in human physiology: what's it all about? J Lipid Res. 44:1268-1278.
111. Sugahara, T., Yang, Y. S., Liu, C. C., Pai, T. G., Liu, M. C. (2003). Sulphonation of dehydroepiandrosterone and neurosteroids: molecular cloning, expression, and functional characterization of a novel zebrafish SULT2 cytosolic sulphotransferase. Biochem. J. 375:785-791.
112. Sugimura, T. (2002). Food and cancer. Toxicology 181-182:17-21.
113. Sullivan, S. D., Moenter, S. M. (2003). Neurosteroids alter gamma-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. Endocrinology 144:4366-4375.
114. Tabrett, C. A., Coughtrie, M. W. H. (2003). Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate. Biochem. Pharmacol. 66:2089-2097.
115. Tan, E., Pang, K. S. (2001). Sulfation is rate limiting in the futile cycling between estrone and estrone sulfate in enriched periportal and perivenous rat hepatocytes. Drug Metab. Dispos. 29:335-346.
116. Taskinen, J., Ethell, B. T., Pihlavisto, P., Hood, A. M., Burchell, B., Coughtrie, M. W. (2003). Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models. Drug Metab. Dispos. 31:1187-1197.
117. Thomae, B. A., Eckloff, B., Freimuth, R. R., Carlini, E., Wieben, E., Weinshilboum, R. M. (2001). Human sulfotransferase (SULT) 2A1 pharmacogenetics: genotype to phenotype studies. Clin. Pharmacol. Ther. 69:94.
118. Thomae, B. A., Rifki, O. F., Theobald, M. A., Eckloff, B. W., Wieben, E. D., Weinshilboum, R. M. (2003). Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. J. Neurochem. 87:809-819.
119. Thomas, N. L., Coughtrie, M. W. (2003). Sulfation of apomorphine by human sulfotransferases: evidence of a major role for the polymorphic phenol sulfotransferase, SULT1A1. Xenobiotica 33:1139-1148.
120. Tiemersma, E. W., Bunschoten, A., Kok, F. J., Glatt, H., de Boer, S. Y., Kampman, E. (2004). Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int. J. Cancer 108:97-103.
121. Tolbert, B. M. (1985). Metabolism and function of ascorbic acid and its metabolites. Int. J. Vitam. Nutr. Res. Suppl. 27:121-138.
122. Visser, T. J. (1994). Role of sulfation in thyroid hormone metabolism. Chem.-Biol. Interact. 92:293-303.
123. Visser, T. J., Kaptein, E., Glatt, H., Bartsch, I., Hagen, M., Coughtrie, M. W. (1998). Characterization of thyroid hormone sulfotransferases. Chem.-Biol. Interact. 109:279-291.
124. Walle, T., Eaton, E. A., Walle, U. K. (1995). Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochem. Pharmacol. 50:731-734.
125. Watabe, T., Ishizuka, T., Isobe, M., Ozawa, N. (1982). A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12- dimethylbenz[alpha]anthracene. Science 215:403-405.
126. Weinshilboum, R., Aksoy, I. (1994). Sulfation pharmacogenetics in humans. Chem.-Biol. Interact. 92:233-246.
127. Weinshilboum, R., Otterness, D. (1994). Sulfotransferase enzymes. In: Kauffman, F. C., ed. Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Berlin: Springer-Verlag, pp. 45-78.
128. Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., Raftogianis, B. B. (1997). Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11:3-14.
129. Whittemore, R. M., Roth, J. A. (1985). Effect of phosphatase inhibition of in vitro dopamine sulfation and 3′-phosphoadenosine-5′- phosphosulfate catabolism in human brain. Biochem. Pharmacol. 34:3853-3856.
130. Witzmann, F., Coughtrie, M., Fultz, C., Lipscomb, J. (1996). Effect of structurally diverse peroxisome proliferators on rat hepatic sulfotransferase. Chem.-Biol. Int. 99:73-84.
131. Xu, Z. H., Otterness, D. M., Freimuth, R. R., Carlini, E. J., Wood, T. C., Mitchell, S., Moon, E., Kim, U. J., Xu, J. P., Siciliano, M. J., Weinshilboum, R. M. (2000). Human 3′-phosphoadenosine 5′- phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization. Biochem. Biophys. Res. Commun. 268:437-444.
132. Xu, Z. H., Thomae, B. A., Eckloff, B. W., Wieben, E. D., Weinshilboum, R. M. (2003). Pharmacogenetics of human 3′-phosphoadenosine 5′-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics, Biochem. Pharmacol. 65:1787-1796.
133. Yanai, H., Javitt, N. B., Higashi, Y., Fuda, H., Strott, C. A. (2004). Expression of cholesterol sulfotransferase (SULT2B1b) in human platelets. Circulation 109:92-96.
134. Zheng, W., Xie, D., Cerhan, J. R., Sellers, T. A., Wen, W., Folsom, A. R. (2001). Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 10:89-94.
135. Zhu, X., Veronese, M. E., Bernard, C. C., Sansom, L. N., McManus, M. E. (1993). Identification of two human brain sulfotransferase cDNAs. Biochem. Biophys. Res. Commun. 195:120-127.
136. Zou, J., Pentney, R., Roth, J. A. (1990). Immunohistochemical detection of phenol sulfotransferase-containing neurons in human brain. J. Neurochem. 55:1154-1158.